Good Riddance Botox: Xeomin is Better And More Affordable Treatment Alternative
In the past year another firm has penetrated the United Sates aesthetics market to compete with the world famous brand Botox, made by the company Allergan. Botox has been unchallenged in the medical cosmetics market in America, with few real alternatives. Till now the main competitor to Botox in America has been Dysport, although many aesthetic doctors have avoided using this version of Botulinum Toxin for in-office aesthetics thanks to some studies suggesting that the drug has a tendency to spread outside the injected muscles.
Merz, a Frankfurt based company, is the maker of Xeomin, a botulinum toxin product. Xeomin has been widely used in Europe and enjoyed by doctors and patients alike. Lately in July 2011, Merz released an announcement that the FDA had approved Xeomin for use in the US and that the product would be available for sale in the spring of 2012. This news is a bonus for aesthetics consumers!
While in the USA Xeomin is a fairly unknown medication it has got many advantages over the more famous injectable Botox. Botox must be either stored in a freezer or refrigerator before reconstitution and is highly sensitive to heat as well as to agitation. For instance, when adding diluent to Botox prior to use, physicians must be extremely careful to insert the solution slowly, since forceful insertion could ruin the toxin and cause it to be ineffective.
Xeomin,as opposed to Botox, is a significantly more durable substance. A substantial advantage over Botox is that Xeomin may be kept in storage at an ambient temperature and so doesn’t necessitate special storage measures. In addition Xeomin is far less sensitive to damage from physical agitation. This means that on the part of the aesthetic practice less ampoules will be harmed due to poor storage.
As opposed to the other Botox alternative, Dysport, Xeomin is much more like Botox apropos its pharmacological profile. Xeomin injections tend to remain extremely localised, that means potentially less complications associated with local spread. Additionally a major advantage is that the units used are identical to the units utilized by Botox, as opposed to Dysport where the units are not identical and can be confusing for doctors.
In addition, if the United States experience follows the UK and Europe, the arrival of Xeomin will lead to competition which will mean cheaper prices for consumers. At the moment the price of Botox in the US is around $9-12 per unit, while the price in England has a tendency to be much lower at $7-8 per unit.
Hence the coming arrival of Xeomin into the States market place will be a blessing for both consumers as well as medical practitioners.
Botox Course runs the best injection course for doctors and dentists to teach them how to inject Botox and run succesful aesthetic medical practices. In addition to the Botox Course, doctors can learn dermal filler injection techniques and chemical peel techniques.
Related posts: